Ontology highlight
ABSTRACT:
SUBMITTER: Pradeep S
PROVIDER: S-EPMC4643364 | biostudies-literature | 2015 Nov
REPOSITORIES: biostudies-literature
Pradeep Sunila S Huang Jie J Mora Edna M EM Nick Alpa M AM Cho Min Soon MS Wu Sherry Y SY Noh Kyunghee K Pecot Chad V CV Rupaimoole Rajesha R Stein Martin A MA Brock Stephan S Wen Yunfei Y Xiong Chiyi C Gharpure Kshipra K Hansen Jean M JM Nagaraja Archana S AS Previs Rebecca A RA Vivas-Mejia Pablo P Han Hee Dong HD Hu Wei W Mangala Lingegowda S LS Zand Behrouz B Stagg Loren J LJ Ladbury John E JE Ozpolat Bulent B Alpay S Neslihan SN Nishimura Masato M Stone Rebecca L RL Matsuo Koji K Armaiz-Peña Guillermo N GN Dalton Heather J HJ Danes Christopher C Goodman Blake B Rodriguez-Aguayo Cristian C Kruger Carola C Schneider Armin A Haghpeykar Shyon S Jaladurgam Padmavathi P Hung Mien-Chie MC Coleman Robert L RL Liu Jinsong J Li Chun C Urbauer Diana D Lopez-Berestein Gabriel G Jackson David B DB Sood Anil K AK
Cancer cell 20151017 5
While recombinant human erythropoietin (rhEpo) has been widely used to treat anemia in cancer patients, concerns about its adverse effects on patient survival have emerged. A lack of correlation between expression of the canonical EpoR and rhEpo's effects on cancer cells prompted us to consider the existence of an alternative Epo receptor. Here, we identified EphB4 as an Epo receptor that triggers downstream signaling via STAT3 and promotes rhEpo-induced tumor growth and progression. In human ov ...[more]